• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Cardiology

[Ann Emerg Med.] Modified Sgarbossa rule associated with improved diagnostic utility for STEMIs

bys25qthea
September 6, 2012
in Cardiology, Surgery
Reading Time: 2 mins read
Share on FacebookShare on TwitterShare on LinkedIn

Image: Sgarbossa's rules. Courtesy of EMS12lead.com

Primer:  In patients presenting with an acute ST Elevated Myocardial Infarction (STEMI) in the presence of a Left Bundle Branch Block (LBBB), infarct diagnosis based on the ECG can be difficult as ST segments and T waves tend to be shifted.  The Sgarbossa rule has been previously proposed as a clinical tool to aid in rapid diagnosis in this scenario. The rule, published in 1996 in the NEJM consists of 3 criteria: 1. Concordant ST elevation > 1mm in leads with a positive QRS (score 5) 2. Concordant ST depression > 1mm in V1-V3 (score 3) 3. Excessively discordant ST elevation > 5mm in leads with a negative QRS (score 2). A total score of ≥ 3 has a specificity of 90% for an acute MI. A score of ≥3 points is interpreted as a positive result using the unweighted rule, while a score of ≥2 points is positive using the weighted rule (any of the three criteria tested positive).

Free ECG reference: Sgarbossa criteria and a modified Sgarbossa calculator

This [retrospective] study: Published on Sept 3rd in the Annals of Emergency Medicine, evaluated the ECGs of 162 subjects admitted for suspected STEMI with LBBB. The study compared the original rule with a modified rule whereby the 3rd component is replaced with an ST/S ratio of less than -0.25 in any one lead. Sensitivity of the revised rule (~91%) was significantly greater than either the weighted (~52%) or unweighted (~67%) Sgarbossa rule (p<.001 and <.008, respectively). The revised rule was significantly more accurate than both the weighted and unweighted Sgarbossa rules. Specificity of the revised rule (~90%) was lower than the weighted rule (~98%) but similar to that of the unweighted rule (~90%).

In sum: Replacement of the 3rd component of the Sgarbossa rule (absolute ST elevation greater than or equal to 5 mm) with an ST/S ratio of less than −0.25 greatly improves the rule's sensitivity and accuracy while only slightly decreasing specificity. As a result, a modified version of the Sgarbossa rule has an improved diagnostic utility for acute STEMI. If confirmed by an independent validation study, the modified criteria could potentially be used as a tool to guide the need for reperfusion therapy in patients with ischemic symptoms and a LBBB. The study’s main limitations included: limited power to detect small changes in sensitivity, the possibility of measurement bias, and the need for validation of the ST/S ratio cut-off point.

Click to read the report in the Annals of Emergency Medicine

RELATED REPORTS

2MM: Pharma Roundup – First DNA therapy approved which could reduce airway surgeries, novel siRNA targets dual lipid pathways, GLP-1s outperform metformin in prediabetes, and Zolgensma tumor risks under FDA review

Tafolecimab monotherapy reduced low-density lipoprotein cholesterol by more than 60% at week 12 in phase 3 CREDIT-5 results

© 2012 2minutemedicine.com. All rights reserved. No works may be republished or reproduced without written consent obtained from 2minutemedicine.com.

Previous Post

[BMJ] Kidney stones associated with increased risk of end-stage renal disease

Next Post

[NEJM] No difference in survival between intermittent androgen deprivation therapy and continuous therapy for prostate cancer patients with rising PSA

RelatedReports

A variety of pharmaceutical items including a vial, capsule, molecule model, pill blister pack, petri dish with a pipette, and a graph, symbolizing drug development.
Pharma Roundup

2MM: Pharma Roundup – First DNA therapy approved which could reduce airway surgeries, novel siRNA targets dual lipid pathways, GLP-1s outperform metformin in prediabetes, and Zolgensma tumor risks under FDA review

November 9, 2026
High cholesterol collage: an artery narrowed by fatty plaque, a bowl of oats, walnuts and a cruet of olive oil
2MM Trial Briefs

Tafolecimab monotherapy reduced low-density lipoprotein cholesterol by more than 60% at week 12 in phase 3 CREDIT-5 results

November 9, 2026
Heart catheter procedures collage: a smiling older man with a white beard and an engraved heart with a blue guidewire
Cardiology

In At-Risk Patients With Moderate Aortic Stenosis, TAVR Reduced 2-Year Death or Heart-Failure Events

November 8, 2026
Sjögren's syndrome collage: a calm older woman, a glass of water, a plain eye drop bottle and a slice of lemon
2MM Trial Briefs

Nipocalimab patient interviews identify mouth dryness as the most important symptom to improve in phase 2 Sjögren’s disease data

November 8, 2026
Next Post

[NEJM] No difference in survival between intermittent androgen deprivation therapy and continuous therapy for prostate cancer patients with rising PSA

[JAMA] Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis

[BMJ] Young women with BRCA1/2 mutations exposed to diagnostic radiation have higher risk of developing breast cancer

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2MM: Pharma Roundup – First DNA therapy approved which could reduce airway surgeries, novel siRNA targets dual lipid pathways, GLP-1s outperform metformin in prediabetes, and Zolgensma tumor risks under FDA review
  • Tafolecimab monotherapy reduced low-density lipoprotein cholesterol by more than 60% at week 12 in phase 3 CREDIT-5 results
  • In At-Risk Patients With Moderate Aortic Stenosis, TAVR Reduced 2-Year Death or Heart-Failure Events
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.